Journal of Controlled Release · 2024 · 16 citations · 55 references
Life SciencesMicrobiologyNutritionFood MicrobiologyGlycobiologyMetabolomicsGut MicrobiomeGut MicrobiotaIntestinal Barrier FunctionMucosal Barrier FunctionEpithelial Barrier RegulationFatty AcidsGut Epithelial Barrier FunctionGut Microbiota EffectsIntestinal Epithelial Barrier FunctionLactate ProductionMicrobial Degradation PathwaysMicrobiome-associated Metabolites
The production of short chain fatty acids (SCFAs) by the colonic microbiome has numerous benefits for human health, including maintenance of epithelial barrier function, suppression of colitis, and protection against carcinogenesis. Despite the therapeutic potential, there is currently no optimal approach for elevating the colonic microbiome's synthesis of SCFAs. In this study, poly(D,l-lactide-co-glycolide) (PLGA) was investigated for this application, as it was hypothesised that the colonic microbiota would metabolise PLGA to its lactate monomers, which would promote the resident microbiota's synthesis of SCFAs. Two grades of spray dried PLGA, alongside a lactate bolus control, were screened in an advanced model of the human colon, known as the M-SHIME® system. Whilst the high molecular weight (Mw) grade of PLGA was stable in the presence of the microbiota sourced from three healthy humans, the low Mw PLGA (PLGA 2) was found to be metabolised. This microbial degradation led to sustained release of lactate over 48 h and increased concentrations of the SCFAs propionate and butyrate. Further, microbial synthesis of harmful ammonium was significantly reduced compared to untreated controls. Interestingly, both types of PLGA were found to influence the composition of the luminal and mucosal microbiota in a donor-specific manner. An in vitro model of an inflamed colonic epithelium also showed the polymer to affect the expression of pro- and anti-inflammatory markers, such as interleukins 8 and 10. The findings of this study reveal PLGA's sensitivity to enzymatic metabolism in the gut, which could be harnessed for therapeutic elevation of colonic SCFAs.
55
NF-κB signaling in inflammation
Ting Liu, Lingyun Zhang, Donghyun Joo et al. · Signal Transduction and Targeted Therapy · 2017 · 8.1K citations · Full text
Life Sciences, Immunology, Pathology +17
James J. Kozich, Sarah L. Westcott, Nielson T. Baxter et al. · Applied and Environmental Microbiology · 2013 · 7.5K citations · Full text
Life Sciences, Ecology, Microbiology +15
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu, Jun Chen, Christian Hoffmann et al. · Science · 2011 · 6.6K citations · Full text
Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
Liping Zhao, Feng Zhang, Xiaoying Ding et al. · Science · 2018 · 2.3K citations